SCLN Financial Facts
Research and development: 3.29MNet income: 10.12M
See Full Income Statement
Commitments and contingencies: 0
Total current assets: 184.24M
See Full Balance Sheet
SciClone Pharmaceuticals, Inc. (SCLN) Earnings
|
Expand Research on SCLN
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +203.3% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +2.1% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 3/31/11 | Q111 | $0.08 | $0.11 | -$0.03 | $23.62M | $23.59M | = |  | | Details | |
| 5/10/11 | Q111 | $0.08 | $0.10 | -$0.02 | $21.7M | $24.32M | = | | | Details | |
| 8/9/11 | Q211 | $0.13 | $0.10 | +$0.03 | $33.1M | $33.36M | = | | | Details | |
11/8/11  |
 |
Q311 | $0.17 | $0.15 | +$0.02 | $37.4M | $37.5M | = | | | Details |
| 3/13/12 |
|
Q411 | $0.20 | $0.12 | +$0.08 | $41.4M | $40.39M |  |
| | Details |
| 5/9/12 | Q112 | $0.15 | $0.14 | +$0.01 | $39.2M | $37.08M | N/A | | | Details | |
| 8/8/12 |
|
Q212 | $0.19 | $0.17 | +$0.02 | $40.3M | $41.98M | |
| | Details |
| 11/9/12 |
Q312 | $0.20 | $0.21 | -$0.01 | $40.7M | $44.8M | |
| | Details |
